Polish Journal of Pathology
eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
Share:
Send email
Share:
Original paper

Vimentin 3 expression in odontogenic keratocysts – a molecular and immunohistochemical study

Ipek Atak Secen
1
,
Heike Goebel
2
,
Emre Barış
1
,
Melanie Freifrau von Brandenstein
3
,
Sibel Elif Gültekin
1

  1. Department of Oral Pathology, Faculty of Dentistry, Gazi University, Ankara, Turkey
  2. Institute of General Pathology and Pathological Anatomy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
  3. Clinic and Polyclinic for Urology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
Pol J Pathol 2025; 76 (4)
DOI: https://doi.org/10.5114/pjp.2025.159041
Online publish date: 2026/02/04
Article file
- Vimentin 3 expression - Secen.pdf  [2.10 MB]
Get citation
 
PlumX metrics:
 
1. Vered M, Wright JM. Update from the 5th edition of the World Health Organization classification of head and neck tumors: odontogenic and maxillofacial bone tumours. Head Neck Pathol 2022; 16: 63-75.
2. Soluk-Tekkesin M, Wright JM. The World Health Organization Classification of odontogenic lesions: a summary of the changes of the 2022 (5th) edition. Turk J Pathol 2022; 38: 168-184.
3. Stoelinga P, Grillo R, da Silva Y. How reliable are follow-up studies on odontogenic keratocysts? Int J Oral Maxillofac Surg 2023: 52: 1156-1161.
4. Modi TG, Chalishazar M, Kumar M. Expression of Ki-67 in odontogenic cysts: a comparative study between odontogenic keratocysts, radicular cysts and dentigerous cysts. J Oral Maxillofac Pathol 2018; 22: 146.
5. Jabbarzadeh M, Hamblin MR, Pournaghi-Azar F, Vakili Saatloo M, Kouhsoltani M, Vahed N. Ki-67 expression as a diagnostic biomarker in odontogenic cysts and tumors: a systematic review and meta-analysis. J Dent Res Dent Clin Dent Prospects 2021; 15: 66-75.
6. Slusarenko da Silva Y, Stoelinga PJW, Grillo R, da Graca Naclerio-Homem M. Cyst or tumor? A systematic review and meta-analysis on the expression of p53 marker in odontogenic keratocysts. J Craniomaxillofac Surg 2021; 49: 1101-1106.
7. Von Brandenstein M, Puetz K, Schlosser M, Loser H, Kallinowski JP, Godde D, et al. Vimentin 3, the new hope, differentiating RCC versus oncocytoma. Dis Mark 2015; 2015: 368534.
8. Von Brandenstein M, Bernhart SH, Pansky A, Richter C, Kohl T, Deckert M, et al. Beyond the 3’UTR binding-microRNA- induced protein truncation via DNA binding. Oncotarget 2018; 9: 32855-3267.
9. Köditz B, Stog A, Göbel H, Heidegger I, Fries J, Heidenreich A, et al. Vimentin 3 expression in prostate cancer cells. Anticancer Res 2021; 41: 169-174.
10. Köditz B, Stog A, Göbel H, Arana MH, Fries J, Heidenreich A, et al. A new prostate cancer surrogate marker-vimentin 3? Open Access J Oncol Med 2021; 4: 402-408.
11. Köditz B, von Brandenstein M, Huerta-Arana M, Heidenreich A, Fries JW. Novel noninvasive marker of regression of clear cell renal cell carcinoma (ccRCC). Turk J Urol 2022; 48: 49.
12. Funke T, von Brandenstein M, Paffenholz P, Köditz B, Nestler T, Herden J, et al. Vimentin 3 allows differentiation between normozoospermia and oligoasthenoteratozoospermia. Dis Mark 2019; 2019: 9803498.
13. Gultekin SE, von Brandenstein M, Baris E, Atak Secen I, Arslan Bozdag L, Goebel H. The role of vimentin 3 in ameloblastomas: a novel tumor biomarker. Oral Dis 2025.
14. Taylor CR, Levenson RM. Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment II. Histopathology 2006; 49: 411-424.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
16. Chitsazan A, Ferguson B, Villani R, Handoko HY, Mukhopadhyay P, Gabrielli B, et al. Keratinocyte sonic hedgehog upregulation drives the development of giant congenital nevi via paracrine endothelin-1á secretion. J Invest Dermatol 2018; 138: 893-902.
17. Von Brandenstein M, Schlosser M, Herden J, Heidenreich A, Störkel S, Fries JWU. MicroRNAs as urinary biomarker for oncocytoma. Dis Mark 2018; 2018: 6979073.
18. Razavi SM, Khalesi S, Torabinia N. Investigation of clinicopathological parameters alongside with p53 expression in primary and recurrent keratocysticodontogenic tumours. Malaysian J Pathol 2014; 36: 105-113.
19. Gadbail AR, Patil R, Chaudhary M. Co-expression of Ki-67 and p53 protein in ameloblastoma and keratocystic odontogenic tumor. Acta Odontol Scand 2012; 70: 529-535.
20. Gomes IP, Bastos VC, Guimaraes LM, Gomes CC. The mole- cular basis of odontogenic cysts and tumours. J Oral Pathol Med 2023; 52: 351-356.
21. Chen P, Liu B, Wei B, Yu S. The clinicopathological features and treatments of odontogenic keratocysts. Am J Cancer Res 2022; 12: 3479.
22. Ghafouri-Fard S, Atarbashi-Moghadam S, Taheri M. Genetic factors in the pathogenesis of ameloblastoma, dentigerous cyst and odontogenic keratocyst. Gene 2021; 771: 145369.
23. Crivelini MM, de Araújo VC, de Sousa SO, de Araújo NS. Cytokeratins in epithelia of odontogenic neoplasms. Oral Dis 2003; 9: 1-6.
24. Nohl EK, Behring J, Kameri E, Köditz B, Nestler T, Heidenreich A, et al. Improved analysis of prostate cancer: VIM3, ATG7 and P53 form a complex and activate miRNA 371a-3p. Anticancer Res 2023; 43: 2407-2416.
25. Nelson JB, Udan MS, Guruli G, Pflug BR. Endothelin-1 inhibits apoptosis in prostate cancer. Neoplasia 2005; 7: 631-637.
26. Koeditz B, Fries JW, Goebel H, Paffenholz P, Richter K, Heidenreich A, et al. Mxi-2 dependent regulation of p53 in prostate cancer. Anticancer Res 2020; 40: 5539-5544.
Copyright: © 2026 Polish Association of Pathologists and the Polish Branch of the International Academy of Pathology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Termedia.